Institutional Trading Of Fennec Pharmaceuticals News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Institutional trading of fennec pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Institutional Trading Of Fennec Pharmaceuticals Today - Breaking & Trending Today

Insider Selling: Fennec Pharmaceuticals Inc (NASDAQ:FENC) CEO Sells 40,584 Shares of Stock

Fennec Pharmaceuticals Inc (NASDAQ:FENC – Get Free Report) CEO Rosty Raykov sold 40,584 shares of the business’s stock in a transaction dated Wednesday, April 3rd. The shares were sold at an average price of $10.78, for a total transaction of $437,495.52. Following the completion of the sale, the chief executive officer now owns 276,054 shares […] ....

United States , Craig Hallum , Rosty Raykov , Allspring Global Investments Holdings , Tower Research Capital , Fennec Pharmaceuticals Price Performance , News Ratings For Fennec Pharmaceuticals Daily , Institutional Trading Of Fennec Pharmaceuticals , Fennec Pharmaceuticals , Fennec Pharmaceuticals Inc , Royal Bank , Quarter For Fennec Pharmaceuticals , Get Free Report , Pharmaceuticals Inc , Research Capital , Sodium Thiosulfate , Fennec Pharmaceuticals Daily , Nasdaq Fenc , Insider Trading , Nsider Trades ,

HC Wainwright Comments on Fennec Pharmaceuticals Inc's Q2 2024 Earnings (NASDAQ:FENC)

HC Wainwright Comments on Fennec Pharmaceuticals Inc's Q2 2024 Earnings (NASDAQ:FENC)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United States , Rosty Raykov , Craig Hallum , Robert Andrade , Institutional Trading Of Fennec Pharmaceuticals , Fennec Pharmaceuticals , Fennec Pharmaceuticals Inc , Fennec Pharmaceuticals Stock Performance , Royal Bank , Barclays Plc , Securities Exchange Commission , Tower Research Capital , Fennec Pharmaceuticals Company Profile , Goldman Sachs Group Inc , Vanguard Group Inc , News Ratings For Fennec Pharmaceuticals Daily , Free Report , Fennec Pharmaceutical , Exchange Commission , Sachs Group , Research Capital , Get Free Report , Pharmaceuticals Inc , Sodium Thiosulfate , Fennec Pharmaceuticals Daily ,

Insider Selling: Fennec Pharmaceuticals Inc (NASDAQ:FENC) CFO Sells 13,975 Shares of Stock

Insider Selling: Fennec Pharmaceuticals Inc (NASDAQ:FENC) CFO Sells 13,975 Shares of Stock
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United States , Robert Andrade , Craig Hallum , Fennec Pharmaceuticals Stock Performance , Quarter For Fennec Pharmaceuticals , Fennec Pharmaceuticals , Institutional Trading Of Fennec Pharmaceuticals , Securities Exchange Commission , Royal Bank , Tower Research Capital , News Ratings For Fennec Pharmaceuticals Daily , Fennec Pharmaceuticals Inc , Get Free Report , Exchange Commission , Pharmaceuticals Inc , Research Capital , California State Teachers Retirement System , Sodium Thiosulfate , Fennec Pharmaceuticals Daily ,

FY2027 EPS Estimates for Fennec Pharmaceuticals Inc Decreased by Analyst (NASDAQ:FENC)

Fennec Pharmaceuticals Inc (NASDAQ:FENC – Free Report) – Investment analysts at Capital One Financial reduced their FY2027 earnings per share estimates for shares of Fennec Pharmaceuticals in a note issued to investors on Thursday, August 3rd. Capital One Financial analyst N. Quibria now anticipates that the company will post earnings of $2.35 per share for […] ....

United States , Gendell Jeffrey , Robert Andrade , Chrisa Rallis , Institutional Trading Of Fennec Pharmaceuticals , Opaleye Management Inc , Capital Management , News Ratings For Fennec Pharmaceuticals Daily , Insider Transactions At Fennec Pharmaceuticals , Fennec Pharmaceuticals Company Profile , Fennec Pharmaceuticals Stock Performance , Dg Capital Management , Fennec Pharmaceuticals Inc , Fennec Pharmaceuticals , Securities Exchange Commission , Free Report , Capital One Financial , One Financial , Fennec Pharmaceutical , Get Free Report , Director Chris , Exchange Commission , Pharmaceuticals Inc , Sodium Thiosulfate , Fennec Pharmaceuticals Daily , Nasdaq Fenc ,

Fennec Pharmaceuticals (FENC) to Release Quarterly Earnings on Thursday

Fennec Pharmaceuticals (NASDAQ:FENC – Get Free Report) will issue its quarterly earnings data before the market opens on Thursday, August 3rd. Analysts expect the company to announce earnings of ($0.18) per share for the quarter. Investors that wish to register for the company’s conference call can do so using this link. Fennec Pharmaceuticals (NASDAQ:FENC – […] ....

United States , Chrisa Rallis , Robert Andrade , Earnings History For Fennec Pharmaceuticals , Fennec Pharmaceuticals Price Performance , Cantor Fitzgerald , Securities Exchange Commission , Institutional Trading Of Fennec Pharmaceuticals , News Ratings For Fennec Pharmaceuticals Daily , Fennec Pharmaceuticals , Boothbay Fund Management , Fennec Pharmaceuticals Inc , Barclays Plc , Jpmorgan Chase Co , America Corp , Get Free Report , Exchange Commission , Director Chris , Fund Management , Pharmaceuticals Inc , Sodium Thiosulfate , Fennec Pharmaceuticals Daily , Nasdaq Fenc ,